19 results
8-K
EX-99.2
XLO
Xilio Therapeutics Inc
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
%) do not have surgery (2) - Primary treatment approach includes chemotherapy and radiation for most patients - Only 2-4% of Stage 4 patients classified
10-K
9rs7u0n985 2c
1 Mar 22
Annual report
4:07pm
10-Q
wq2mj3rof6f9l
2 Dec 21
Quarterly report
4:15pm
8-K
qn091qf8al68dtf0n6
26 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
424B4
w74np ziw6
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
3awquv4susd1u
18 Oct 21
IPO registration (amended)
6:04am
S-1
9pfbvc73pdmnz bem
1 Oct 21
IPO registration
4:49pm
DRSLTR
x6lq2rcf
14 Sep 21
Correspondence regarding draft registration statement
12:00am
DRS/A
pggxe
14 Sep 21
Draft registration statement (amended)
12:00am
UPLOAD
ssgjg4p
21 Jun 21
Letter from SEC
12:00am
DRS
o3lajyowhk1270 ae9
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next